REQUEST A DEMO
Total
USD $0.00
Search more companies

Troikaa Pharmaceuticals Philippines, Inc. (Philippines)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers | Wholesale Trade Agents and Brokers | Pharmacies and Drug Stores
Full name: Troikaa Pharmaceuticals Philippines, Inc. Profile Updated: June 23, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Troikaa Pharmaceuticals Philippines, Inc. is an enterprise based in Philippines. Its main office is in Pasig City. It operates in the Other Miscellaneous Nondurable Goods Merchant Wholesalers industry. Troikaa Pharmaceuticals Philippines, Inc. was incorporated on December 02, 2015. The latest financial highlights indicate a net sales revenue increase of 58.64% in 2024. There was a total growth of 51.8% in Troikaa Pharmaceuticals Philippines, Inc.’s total assets over the same period. The net profit margin of Troikaa Pharmaceuticals Philippines, Inc. decreased by 0.22% in 2024.

Headquarters
Unit 505 Richmonde Plaza, Lourdes Drive Corner Pearl Drive, Ortigas Center
Pasig City; Metro Manila;

Contact Details: Purchase the Troikaa Pharmaceuticals Philippines, Inc. report to view the information.

Basic Information
Financial Auditors:
Purchase the Troikaa Pharmaceuticals Philippines, Inc. report to view the information.
Incorporation Date:
December 02, 2015
Key Executives
Purchase this report to view the information.
Chairman and Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Troikaa Pharmaceuticals Philippines, Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PHP. Absolute financial data is included in the purchased report.
Net sales revenue
58.64%
Total Operating Revenue
58.64%
Net Profit/Loss for the Period
40.47%
Total Assets
51.8%
Total Equity
37.36%
Net Profit Margin
-0.22%
Return on Equity (ROE)
0.44%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?